» Articles » PMID: 38322017

ANOCA Patients with and Without Coronary Vasomotor Dysfunction Present with Limited Electrocardiographic Remodeling

Abstract

Background: Coronary vasomotor dysfunction (CVDys) comprises coronary vasospasm (CVS) and/or coronary microvascular dysfunction (CMD) and is highly prevalent in patients with angina and non-obstructive coronary artery disease (ANOCA). Invasive coronary function testing (CFT) to diagnose CVDys is becoming more common, enabling pathophysiologic research of CVDys. This study aims to explore the electrophysiological characteristics of ANOCA patients with CVDys.

Methods: We collected pre-procedural 12-lead electrocardiograms of ANOCA patients with CVS (n = 35), CMD (n = 24), CVS/CMD (n = 26) and patients without CVDys (CFT-, n = 23) who participated in the NL-CFT registry and underwent CFT. Heart axis and conduction times were compared between patients with CVS, CMD or CVS/CMD and patients without CVDys.

Results: Heart axis, heart rate, PQ interval and QRS duration were comparable between the groups. A small prolongation of the QT-interval corrected with Bazett (QTcB) and Fridericia (QTcF) was observed in patients with CVDys compared to patients without CVDys (CVS vs CFT-: QTcB = 422 ± 18 vs 414 ± 18 ms (p = 0.14), QTcF = 410 ± 14 vs 406 ± 12 ms (p = 0.21); CMD vs CFT-: QTcB = 426 ± 17 vs 414 ± 18 ms (p = 0.03), QTcF = 413 ± 11 vs 406 ± 12 ms (p = 0.04); CVS/CMD vs CFT-: QTcB = 424 ± 17 vs 414 ± 18 ms (p = 0.05), QTcF = 414 ± 14 vs 406 ± 12 ms (p = 0.04)).

Conclusions: Pre-procedural 12-lead electrocardiograms were comparable between patients with and without CVDys undergoing CFT except for a slightly longer QTc interval in patients with CVDys compared to patients without CVDys, suggesting limited cardiac remodeling in patients with CVDys.

References
1.
Luo S, Michler K, Johnston P, Macfarlane P . A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol. 2004; 37 Suppl:81-90. DOI: 10.1016/j.jelectrocard.2004.08.030. View

2.
Jansen T, Elias-Smale S, van den Oord S, Gehlmann H, Dimitiriu-Leen A, Maas A . Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease. Front Cardiovasc Med. 2021; 8:750071. PMC: 8551605. DOI: 10.3389/fcvm.2021.750071. View

3.
Taqueti V, Solomon S, Shah A, Desai A, Groarke J, Osborne M . Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018; 39(10):840-849. PMC: 5939665. DOI: 10.1093/eurheartj/ehx721. View

4.
Sara J, Lennon R, Ackerman M, Friedman P, Noseworthy P, Lerman A . Coronary microvascular dysfunction is associated with baseline QTc prolongation amongst patients with chest pain and non-obstructive coronary artery disease. J Electrocardiol. 2015; 49(1):87-93. DOI: 10.1016/j.jelectrocard.2015.10.006. View

5.
Brainin P, Frestad D, Prescott E . The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis. Int J Cardiol. 2018; 254:1-9. DOI: 10.1016/j.ijcard.2017.10.052. View